Hikma is introducing naloxone hydrochloride injection, 2mg/2ml, in a prefilled syringe form. The drug is used for the emergency treatment of a known or suspected opioid overdose and is the third ...

Zimhi ™ (naloxone hydrochloride) injection is now available for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression.

Dr. Reddy’s Laboratories announced the availability of Naloxone Hydrochloride Injection, a therapeutic equivalent generic version of Narcan® (naloxone hydrochloride; Adapt), in 2mg/2mL single ...

LOUISVILLE, Ky.-- (BUSINESS WIRE)--Today is International Overdose Awareness Day, and ZIMHI™ (naloxone HCL injection), a higher-dose naloxone product approved for use in the treatment of opioid ...

Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe ...

Dr. Reddy’s has announced its first-to-market launch of naloxone hydrochloride injection in a dosage strength of 2 mg/2 mL (1 mg/mL). It is available in a 2 mL single-dose prefilled syringe.

According to IQVIA Health, the Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) had U.S. sales of approximately $31 million for the most recent twelve months ending in January 2020.

The recall includes lots 72680LL and 76510LL of Naloxone Hydrochloride Injection dated "1DEC2018" and "1APR2019" respectively. The medication is packaged in single-use cartridge syringes.

Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe ...

RICHMOND, Va., Jan. 11, 2018 /PRNewswire/ -- kaléo, a privately-held pharmaceutical company, today announced that EVZIO ® (naloxone HCl injection) Auto-injectors have been reported to help save ...

Advertisement Naloxone Hydrochloride Injection USP, 0.4 mg/mL, had U.S. sales of approximately $12.3 million for the 12 months ending Dec. 31, 2013, according to IMS Health. Advertisement ...

A version of narcan has been recalled.Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL ...